Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check59 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check66 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check110 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.